BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12901231)

  • 21. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WT1 peptide vaccine for the treatment of cancer.
    Oka Y; Tsuboi A; Oji Y; Kawase I; Sugiyama H
    Curr Opin Immunol; 2008 Apr; 20(2):211-20. PubMed ID: 18502632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of tumor cell-based vaccines.
    Copier J; Dalgleish A
    Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic cancer vaccines.
    Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
    Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology Insight: vaccine therapy for prostate cancer.
    Vieweg J; Dannull J
    Nat Clin Pract Urol; 2005 Jan; 2(1):44-51. PubMed ID: 16474576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review. Colon cancer vaccines: an update.
    Merika E; Saif MW; Katz A; Syrigos K; Morse M
    In Vivo; 2010; 24(5):607-28. PubMed ID: 20952724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future directions for vaccine-based therapies.
    Vieweg J
    Urol Oncol; 2006; 24(5):448-55. PubMed ID: 16962498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy and the development of cancer vaccines.
    Dalgleish AG
    Expert Rev Vaccines; 2006 Feb; 5(1):1-4. PubMed ID: 16451100
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination as a treatment for breast or ovarian cancer.
    Holmberg LA; Sandmaier B
    Expert Rev Vaccines; 2004 Jun; 3(3):269-77. PubMed ID: 15176943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical results of vaccine therapy for cancer: learning from history for improving the future.
    Choudhury A; Mosolits S; Kokhaei P; Hansson L; Palma M; Mellstedt H
    Adv Cancer Res; 2006; 95():147-202. PubMed ID: 16860658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor vaccination using messenger RNA: prospects of a future therapy.
    Kreiter S; Diken M; Selmi A; Türeci Ö; Sahin U
    Curr Opin Immunol; 2011 Jun; 23(3):399-406. PubMed ID: 21497074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma vaccines: achievements and perspectives.
    Brichard VG; Gérard C
    Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer vaccines: challenges and outlook in the field.
    Paul S; Acres B; Limacher JM; Bonnefoy JY
    IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination: role in metastatic melanoma.
    Pilla L; Valenti R; Marrari A; Patuzzo R; Santinami M; Parmiani G; Rivoltini L
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1305-18. PubMed ID: 16925496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine therapy for renal cancer.
    Amato RJ
    Expert Rev Vaccines; 2008 Sep; 7(7):925-35. PubMed ID: 18767943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.